More than 99 percent of Americans born before 1980 had chickenpox, whether they remember the oatmeal baths or not. Here is the part nobody mentioned back then. That virus never packed up and left.
It moved into the nerve cells near your spine, pulled the shades, and has been sitting there quietly for 60 or 70 years, waiting for your immune system to look the other way. When it wakes up, we call it shingles, and about 1 in 3 of us will meet it eventually.
I used to think shingles was something that happened to other people, like jury duty. Then a neighbor spent an evening describing hers, and I signed up for the vaccine the following week.
What Is Actually Hiding in There
Shingles is not a fresh infection you catch from a doorknob. It is an old one coming back for an encore. The culprit is the varicella-zoster virus, the same one that gave you chickenpox as a child.
After the itching stopped, the virus retreated into the nerve cells near your spine, in a cluster doctors call the dorsal root ganglia, and went dormant. It can stay quiet for decades.
What keeps it quiet is your immune system, standing guard. As we age, that guard gets a little sleepy, and the virus sees its opening. That is why shingles is largely a second-half-of-life problem.
The CDC says about 1 in 3 people in the United States will develop shingles in their lifetime, and the risk rises with age. It is not bad luck or poor hygiene. It is simply the arithmetic of a long life and a virus with a very good memory.
The Pain That Outstays Its Welcome
The rash itself is bad enough. It usually wraps around one side of the torso or face in a painful band of blisters, following the path of a single nerve. For most people it clears in a few weeks.
The real villain is what can come after. Between 10 and 15 percent of people who get shingles go on to develop postherpetic neuralgia, a nerve pain that lingers in the same spot long after the rash is gone.
It can last months. For some unlucky folks it lasts years. People describe it as burning, stabbing, or a skin so tender that a bedsheet feels like sandpaper. The risk of this lingering pain climbs with age, which is the cruel twist.
The people most likely to get shingles are also the most likely to be stuck with the aftermath. There is no reliable way to know in advance whether you will be one of the lucky ones who heals in a month, or one who spends a year chasing relief.
That uncertainty is exactly why prevention gets so much attention.
Shingrix and the Two-Dose Rule
There is one shingles vaccine available in the United States today, and its name is Shingrix. The FDA licensed it in 2017, and it quickly became the preferred choice. The older vaccine, Zostavax, was pulled from the American market in 2020.
Shingrix is not a single jab. It comes in two doses, given 2 to 6 months apart, and both of them matter, which I will come back to. The CDC recommends it for all healthy adults 50 and older, and for adults 19 and older whose immune systems are weakened by illness or treatment.
Here is the part that surprises people. You should get it even if you already had shingles, even if you had chickenpox, and even if you got the old Zostavax years ago. Past shingles does not make you immune, because the virus can return more than once.
There is no blood test to see whether you need it. If you had chickenpox, and almost everyone born before 1980 did, the virus is already in you. The recommendation is based on your age, not your history.
How Well It Works
Vaccines rarely post numbers this good. In the clinical trials, two doses of Shingrix were about 97 percent effective at preventing shingles in healthy adults ages 50 to 69.
In adults 70 and older, whose immune systems have more ground to make up, it was about 91 percent effective. Against postherpetic neuralgia, that lingering pain, it was roughly 91 percent effective in adults over 50.
Protection also holds up over time. Studies have found it staying strong for at least 7 years, and newer research suggests meaningful protection stretching toward 11 years.
For now there is no recommendation for a booster, though that could change as the long-term data grows. One caution is worth repeating. The two doses work as a team. Among people who got only the first shot and skipped the second, protection fell off quickly and dropped to around 52 percent by the third year.
That is the difference between a vaccine that mostly works and one that barely does. Finishing the series is not a suggestion. It is the whole point.
The Price Changed in 2023
For years, cost was the quiet reason people put this vaccine off. Without coverage, the two doses are a real bill, a few hundred dollars, and plenty of folks decided to gamble instead.
The rules changed on January 1, 2023. Under the Inflation Reduction Act, all adult vaccines recommended by the CDC's advisory committee became free under Medicare Part D, with no deductible, no copay, and no coinsurance.
Shingrix is on that list. For most people with a Part D plan, or a Medicare Advantage plan that includes drug coverage, the price today is $0. One wrinkle trips people up.
Original Medicare, meaning Part A and Part B, does not cover the shingles vaccine. The coverage lives in Part D. And because of how Part D billing works, most people with Part D get the shot at a pharmacy rather than a doctor's office.
Many doctors cannot bill Part D for it. So the simplest path is usually to call your pharmacy, confirm they have it in stock, and bring your Part D or Advantage card.
The Second Shot Everyone Forgets
If there is one thing I want to nail to the refrigerator, it is this. Go back for dose two. Life gets busy, the first shot leaves you with a sore arm, and the follow-up slides off the calendar.
But as we saw, skipping it leaves you with a fraction of the protection. Mark the second dose when you get the first. Anywhere from 2 to 6 months later is the window. A word on side effects, because they are worth knowing before you panic.
Shingrix can make you feel lousy for a day or two. A sore arm, tiredness, muscle aches, headache, and sometimes a low fever. It is a sign your immune system is doing exactly what you asked it to do.
The discomfort fades fast. Many people schedule the shot for a day when they can take it easy afterward, maybe a Friday, so a quiet weekend can absorb the grumbles. Compared with weeks of blistering rash, or months of nerve pain, a rough afternoon is a bargain I will take every time.
Shingles and Shingrix at a Glance
| Item | Detail |
|---|---|
| Cause | Reactivation of the varicella-zoster virus, the chickenpox virus |
| Lifetime risk | About 1 in 3 people in the United States |
| Vaccine | Shingrix, two doses, 2 to 6 months apart |
| Who should get it | Healthy adults 50 and older; immunocompromised adults 19 and older |
| Cost under Part D | $0 since January 1, 2023 |
| Where most people get it | A pharmacy, not usually a doctor's office |
Shingles is one of those risks that feels abstract right up until it is not. The virus has been a patient houseguest since your chickenpox days, and the only question is whether it ever decides to make trouble.
You cannot control that. You can control whether you are protected. If you are 50 or older, ask about Shingrix at your next visit, or call the pharmacy this week. Confirm it is covered under your Part D plan, get the first dose, and write the date of the second one down somewhere you will actually look.
Then go enjoy your weekend. This is one of the rare chores in life that is cheap, quick, and genuinely worth the sore arm.
Sources
- CDC, Shingles Vaccination, cdc.gov (2024)
- CDC, About Shingles (Herpes Zoster), cdc.gov (2024)
- Advisory Committee on Immunization Practices (ACIP), Recombinant Zoster Vaccine Recommendations, MMWR (2018, 2022)
- GSK, Shingrix Cost and Coverage, shingrix.com (2023)
- National Council on Aging, Shingles Vaccine: Cost, Medicare Coverage, and Who Should Get It (2024)